Literature DB >> 17652006

A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown.

Gretchen M Miller1, Richard Stripp.   

Abstract

In America, recent growth in the popularity of Chinese herbal/patent medicines (CHM/CPM) has generated concerns as to the safety of these and other herbal remedies. Lack of strict federal regulations has lead to the possibility of improper labeling and even adulteration of these products with western drugs or other chemical contaminants. Our laboratory has conducted an analytical study to determine the presence of undeclared pharmaceuticals and therapeutic substances within CHM/CPM sold in New York City's Chinatown. Ninety representative samples randomly purchased in the form of pills, tablets, creams and teas were screened by appropriate analytical techniques including TLC, GC/MS and HPLC. Five samples contained nine different western pharmaceuticals. Two of these samples contained undeclared or mislabeled substances. One sample contained two pharmaceuticals contraindicated in people for whom the product was intended. Drugs identified include promethazine, chlormethiazole, chlorpheniramine, diclofenac, chlordiazepoxide, hydrochlorothiazide, triamterene, diphenhydramine and sildenafil citrate (Viagra).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652006     DOI: 10.1016/j.legalmed.2007.04.001

Source DB:  PubMed          Journal:  Leg Med (Tokyo)        ISSN: 1344-6223            Impact factor:   1.376


  8 in total

1.  Chinese slimming capsules containing sibutramine sold over the Internet: a case series.

Authors:  Dieter Müller; Wolfgang Weinmann; Maren Hermanns-Clausen
Journal:  Dtsch Arztebl Int       Date:  2009-03-27       Impact factor: 5.594

2.  Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.

Authors:  Victor J Navarro; Huiman Barnhart; Herbert L Bonkovsky; Timothy Davern; Robert J Fontana; Lafaine Grant; K Rajender Reddy; Leonard B Seeff; Jose Serrano; Averell H Sherker; Andrew Stolz; Jayant Talwalkar; Maricruz Vega; Raj Vuppalanchi
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

Review 3.  Concomitant use of prescription medications and dietary supplements in menopausal women: an approach to provider preparedness.

Authors:  Paula Gardiner; Mitchell Bebel Stargrove; Tieraona Low Dog
Journal:  Maturitas       Date:  2010-12-17       Impact factor: 4.342

Review 4.  Drug-Induced Liver Injury in GI Practice.

Authors:  Naemat Sandhu; Victor Navarro
Journal:  Hepatol Commun       Date:  2020-03-13

Review 5.  Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.

Authors:  Mark I Avigan; Robert P Mozersky; Leonard B Seeff
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

6.  Spectroscopic and Spectrometric Methods Used for the Screening of Certain Herbal Food Supplements Suspected of Adulteration.

Authors:  Cristina Mateescu; Anca Mihaela Popescu; Gabriel Lucian Radu; Tatiana Onisei; Adina Elena Raducanu
Journal:  Adv Pharm Bull       Date:  2017-06-30

7.  The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.

Authors:  Shang-Chen Yang; Sindy Hu; Sheng-Zheng Zhang; Jin-Wen Huang; Jing Zhang; Chao Ji; Bo Cheng
Journal:  J Immunol Res       Date:  2018-02-11       Impact factor: 4.818

Review 8.  Benefits and Limitations of DNA Barcoding and Metabarcoding in Herbal Product Authentication.

Authors:  Ancuta Cristina Raclariu; Michael Heinrich; Mihael Cristin Ichim; Hugo de Boer
Journal:  Phytochem Anal       Date:  2017-09-14       Impact factor: 3.373

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.